☰

Christina M. Woo, Ph.D. - Publications

Affiliations: 
2016- Harvard University, Cambridge, MA, United States 
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Park SM, Miyamoto DK, Han GYQ, Chan M, Curnutt NM, Tran NL, Velleca A, Kim JH, Schurer A, Chang K, Xu W, Kharas MG, Woo CM. Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells. Cancer Cell. PMID 36898380 DOI: 10.1016/j.ccell.2023.02.010  0.737
2022 Ichikawa S, Flaxman HA, Xu W, Vallavoju N, Lloyd HC, Wang B, Shen D, Pratt MR, Woo CM. The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron. Nature. 610: 775-782. PMID 36261529 DOI: 10.1038/s41586-022-05333-5  0.567
2021 Jackson EG, Cutolo G, Yang B, Yarravarapu N, Burns MWN, Bineva-Todd G, Roustan C, Thoden JB, Lin-Jones HM, van Kuppevelt TH, Holden HM, Schumann B, Kohler JJ, Woo CM, Pratt MR. 4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic Chemical Reporter of O-GlcNAc Modifications, Highlighting the Notable Substrate Flexibility of O-GlcNAc Transferase. Acs Chemical Biology. PMID 34931806 DOI: 10.1021/acschembio.1c00818  0.772
2021 Yu W, Lin Z, Woo CM, Baskin JM. A Chemoproteomics Approach to Profile Phospholipase D-Derived Phosphatidyl Alcohol Interactions. Acs Chemical Biology. PMID 34908404 DOI: 10.1021/acschembio.1c00584  0.464
2021 Ge Y, Woo CM. Writing and erasing O-GlcNAc from target proteins in cells. Biochemical Society Transactions. PMID 34783346 DOI: 10.1042/BST20210865  0.361
2021 Ramirez DH, Yang B, D'Souza AK, Shen D, Woo CM. Truncation of the TPR domain of OGT alters substrate and glycosite selection. Analytical and Bioanalytical Chemistry. PMID 34725712 DOI: 10.1007/s00216-021-03731-8  0.627
2021 Ramirez DH, Ge Y, Woo CM. O-GlcNAc Engineering on a Target Protein in Cells with Nanobody-OGT and Nanobody-splitOGA. Current Protocols. 1: e117. PMID 33950562 DOI: 10.1002/cpz1.117  0.649
2021 Ge Y, Ramirez DH, Yang B, D'Souza AK, Aonbangkhen C, Wong S, Woo CM. Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase. Nature Chemical Biology. PMID 33686291 DOI: 10.1038/s41589-021-00757-y  0.776
2020 Darabedian N, Yang B, Ding R, Cutolo G, Zaro BW, Woo CM, Pratt MR. O-Acetylated Chemical Reporters of Glycosylation Can Display Metabolism-Dependent Background Labeling of Proteins but Are Generally Reliable Tools for the Identification of Glycoproteins. Frontiers in Chemistry. 8: 318. PMID 32411667 DOI: 10.3389/Fchem.2020.00318  0.615
2020 Schwein PA, Woo CM. The O-GlcNAc Modification on Kinases. Acs Chemical Biology. PMID 32155042 DOI: 10.1021/acschembio.9b01015  0.306
2020 Ramirez DH, Aonbangkhen C, Wu HY, Naftaly JA, Tang S, O'Meara TR, Woo CM. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells. Acs Chemical Biology. PMID 32119511 DOI: 10.1021/Acschembio.0C00074  0.779
2019 Joiner CM, Levine ZG, Aonbangkhen C, Woo CM, Walker S. Aspartate residues far from the active site drive O-GlcNAc transferase substrate selection. Journal of the American Chemical Society. PMID 31373491 DOI: 10.1021/Jacs.9B06061  0.733
2018 Darabedian N, Gao J, Chuh KN, Woo CM, Pratt MR. The metabolic chemical reporter 6-azido-6-deoxy-glucose further reveals the substrate promiscuity of O-GlcNAc transferase and catalyzes the discovery of intracellular protein modification by O-glucose. Journal of the American Chemical Society. PMID 29771506 DOI: 10.1021/Jacs.7B13488  0.605
2018 Woo CM, Lund PJ, Huang AC, Davis MM, Bertozzi CR, Pitteri S. Mapping and quantification of over 2,000 O-linked glycopeptides in activated human T cells with isotope-targeted glycoproteomics (IsoTaG). Molecular & Cellular Proteomics : McP. PMID 29351928 DOI: 10.1074/Mcp.Ra117.000261  0.502
2017 Woo CM, Felix A, Byrd WE, Zuegel DK, Ishihara M, Azadi P, Iavarone AT, Pitteri SJ, Bertozzi CR. Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes. Journal of Proteome Research. PMID 28244757 DOI: 10.1021/Acs.Jproteome.6B01053  0.505
2016 Woo CM, Felix A, Zhang L, Elias JE, Bertozzi CR. Isotope-targeted glycoproteomics (IsoTaG) analysis of sialylated N- and O-glycopeptides on an Orbitrap Fusion Tribrid using azido and alkynyl sugars. Analytical and Bioanalytical Chemistry. PMID 27695962 DOI: 10.1007/S00216-016-9934-9  0.533
2016 Sheta R, Roux-Dalvai F, Woo CM, Fournier F, Bourassa S, Bertozzi CR, Droit A, Bachvarov D. Proteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. Data in Brief. 8: 342-9. PMID 27331112 DOI: 10.1016/J.Dib.2016.05.060  0.417
2016 Sheta R, Woo CM, Roux-Dalvai F, Fournier F, Bourassa S, Droit A, Bertozzi CR, Bachvarov D. A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells. Journal of Proteomics. PMID 27095597 DOI: 10.1016/J.Jprot.2016.04.009  0.424
2016 Woo CM, Bertozzi CR. Isotope Targeted Glycoproteomics (IsoTaG) to Characterize Intact, Metabolically Labeled Glycopeptides from Complex Proteomes. Current Protocols in Chemical Biology. 8: 59-82. PMID 26995354 DOI: 10.1002/9780470559277.Ch150185  0.457
2016 Woo CM, Li Z, Paulson EK, Herzon SB. Structural basis for DNA cleavage by the potent antiproliferative agent (-)-lomaiviticin A. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929332 DOI: 10.1073/Pnas.1519846113  0.588
2015 Woo CM, Iavarone AT, Spiciarich DR, Palaniappan KK, Bertozzi CR. Isotope-targeted glycoproteomics (IsoTaG): a mass-independent platform for intact N- and O-glycopeptide discovery and analysis. Nature Methods. 12: 561-7. PMID 25894945 DOI: 10.1038/Nmeth.3366  0.679
2014 Woo CM, Ranjan N, Arya DP, Herzon SB. Analysis of diazofluorene DNA binding and damaging activity: DNA cleavage by a synthetic monomeric diazofluorene. Angewandte Chemie (International Ed. in English). 53: 9325-8. PMID 25044348 DOI: 10.1002/Anie.201404137  0.586
2014 Colis LC, Woo CM, Hegan DC, Li Z, Glazer PM, Herzon SB. The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA. Nature Chemistry. 6: 504-10. PMID 24848236 DOI: 10.1038/Nchem.1944  0.602
2013 Woo CM, Gholap SL, Herzon SB. Insights into lomaiviticin biosynthesis. Isolation and structure elucidation of (-)-homoseongomycin. Journal of Natural Products. 76: 1238-41. PMID 23803003 DOI: 10.1021/Np400355H  0.751
2012 Woo CM, Gholap SL, Lu L, Kaneko M, Li Z, Ravikumar PC, Herzon SB. Development of enantioselective synthetic routes to (-)-kinamycin F and (-)-lomaiviticin aglycon. Journal of the American Chemical Society. 134: 17262-73. PMID 23030272 DOI: 10.1021/Ja307497H  0.733
2012 Woo CM, Beizer NE, Janso JE, Herzon SB. Isolation of lomaiviticins C-E, transformation of lomaiviticin C to lomaiviticin A, complete structure elucidation of lomaiviticin A, and structure-activity analyses. Journal of the American Chemical Society. 134: 15285-8. PMID 22963534 DOI: 10.1021/Ja3074984  0.57
2012 Herzon SB, Woo CM. The diazofluorene antitumor antibiotics: structural elucidation, biosynthetic, synthetic, and chemical biological studies. Natural Product Reports. 29: 87-118. PMID 22037715 DOI: 10.1039/C1Np00052G  0.629
2012 Mulcahy SP, Woo CM, Ding W, Ellestad GA, Herzon SB. Characterization of a reductively-activated elimination pathway relevant to the biological chemistry of the kinamycins and lomaiviticins Chemical Science. 3: 1070-1074. DOI: 10.1039/C2Sc00854H  0.619
2011 Herzon SB, Lu L, Woo CM, Gholap SL. 11-Step enantioselective synthesis of (-)-lomaiviticin aglycon. Journal of the American Chemical Society. 133: 7260-3. PMID 21280607 DOI: 10.1021/Ja200034B  0.757
2010 Woo CM, Lu L, Gholap SL, Smith DR, Herzon SB. Development of a convergent entry to the diazofluorene antitumor antibiotics: enantioselective synthesis of kinamycin F. Journal of the American Chemical Society. 132: 2540-1. PMID 20141138 DOI: 10.1021/Ja910769J  0.757
2009 Gholap SL, Woo CM, Ravikumar PC, Herzon SB. Synthesis of the fully glycosylated cyclohexenone core of lomaiviticin A. Organic Letters. 11: 4322-5. PMID 19719089 DOI: 10.1021/Ol901710B  0.753
Show low-probability matches.